The aim of the Juvenile Diabetes Cure Alliance is to see a Practical Cure for type 1 diabetes become widely available in the next 15 years.

  • JDCA COMMUNITY SIZE. MEMBERS, DONORS, VOLUNTEERS

    400,000

  • T1D FREE REPORTS PUBLISHED

    500+

  • # OF YEARS PUBLISHING THE DEFINITIVE STATE OF THE CURE FOR T1D

    9

  • MORE-FOR-A-T1D-CURE PETITION SIGNATURES

    351,000

Latest Research & Reports

This report provides an overview of all the type 1 diabetes research projects currently active in human trials registered with the US FDA.

JDRF’s 2021 Fiscal Year endured the full force of COVID-19, stretching from July 2020 to June 2021. During this period, many organizations saw a contraction in revenue and, in response, reduced expenses substantially. JDRF cut expenses but, at the same time, surprisingly, experienced near record-high income.

This morning, Vertex Pharmaceuticals announced that it will acquire the private biotech startup ViaCyte for $320 million in cash. The deal will bring together two companies that have been competing to develop a Practical Cure for T1D.

Vertex Pharmaceuticals announced on Tuesday that the FDA will allow the company to continue its human trial of VX-880, the novel line of insulin-producing cells derived from stem cells.

Last weekend, The Human Trial, a must-see film for anyone interested in the effort to cure type 1 diabetes, opened in select cities across the United States.

This report will analyze the American Diabetes Association (ADA) Fiscal Year 2021 Audited Financial Statements, which cover a period from January 1, 2021 to December 31, 2021.

Why we continue advocating for a T1D cure everyday...

  • Voices of the Cure Petition

    "I signed for my Granddaughter Addison. Our world is a brighter place with her in it. She is such a trooper with everything she has gone through and she knows so much about her disease. Praying for a cure, as this is such a horrible disease" -- Renee B.

Subscribe for the Latest T1D Practical Cure News & Analysis

* indicates required
Join the mailing list!
Join the mailing list!

When you join our email list, you'll be the first to hear all the latest T1D Practical Cure news.